Protalix BioTherapeutics Inc Stock Forecast
Protalix BioTherapeutics Inc stock upgraded from Strong Sell Candidate to Sell Candidate after Tuesday trading session.
(Updated on May 07, 2024)
The Protalix BioTherapeutics Inc stock price gained 2.70% on the last trading day (Tuesday, 7th May 2024), rising from $1.11 to $1.14. During the last trading day the stock fluctuated 3.57% from a day low at $1.12 to a day high of $1.16. The price has fallen in 6 of the last 10 days and is down by -5% for this period. Volume fell on the last day by -783 thousand shares and in total, 225 thousand shares were bought and sold for approximately $256.20 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.91% during the next 3 months and, with a 90% probability hold a price between $0.81 and $0.95 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PLX Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, May 06, 2024, and so far it has risen 2.70%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protalix BioTherapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.16 and $1.21. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Protalix BioTherapeutics Inc stock
Protalix BioTherapeutics Inc finds support from accumulated volume at $1.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.57%. For the last week the stock has had daily average volatility of 5.76%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (PLX) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect Protalix BioTherapeutics Inc to open at $1.14, and during the day (based on 14 day Average True Range), to move between $1.07 and $1.21, which gives a possible trading interval of +/-$0.0722 (+/-6.34%) up or down from last closing price. If Protalix BioTherapeutics Inc takes out the full calculated possible swing range there will be an estimated 12.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.15 (0.88%) than the support at $1.13 (0.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Protalix BioTherapeutics Inc will release earnings BMO on Friday, May 10, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0200. We will update the financials statements for Protalix BioTherapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.63% in the first trading day after earnings release.
Is Protalix BioTherapeutics Inc stock A Buy?
Protalix BioTherapeutics Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -1.425 Sell Candidate Upgraded
Predicted Opening Price for Protalix BioTherapeutics Inc of Wednesday, May 8, 2024
| Fair opening price May 8, 2024 | Current price |
|---|---|
| $1.14 ( 0%) | $1.14 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PLX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.18 | 3.51 % | |
| R2 | 1.16 | 2.17 % | ||
| R1 | 1.16 | 1.34 % | ||
| Current price: | 1.14 | |||
| Support | S1 | 1.12 | -1.34 % | |
| S2 | 1.12 | -2.17 % | ||
| S3 | 1.10 | -3.51 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.30 | 14.04 % | |
| R2 | 1.22 | 7.02 % | ||
| R1 | 1.15 | 0.88 % | ||
| Current price | 1.14 | |||
| Support | S1 | 1.13 | -0.88% | |
| S2 | 1.11 | -2.63% | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Protalix BioTherapeutics Inc Stock.
